Study Reveals Causes of Premature Death in Testicular Cancer Survivors
Certain treatments were associated with an increased risk of death unrelated to testicular cancer.
Genitourinary Cancer
Nursing Cases: Nurse Advocates for Patient’s Participation in Shared Decision Making
A nurse coordinated a meeting to ensure the patient’s preferences were shared with his multidisciplinary care team.
Pembrolizumab Monotherapy for BCG-Unresponsive, Non–Muscle-Invasive Bladder Cancer
Patients with BCG-unresponsive, non–muscle-invasive bladder cancer who received pembrolizumab had a complete response rate of 41%.
ctDNA Testing May Guide Precision Treatment in Urothelial Carcinoma
Patients who have ctDNA-positive urothelial carcinoma were found to be at higher risk for disease recurrence than those with a ctDNA-negative status.
No Benefit With Adjuvant Atezolizumab in Muscle-Invasive Urothelial Carcinoma
The aim of the trial was to determine if adjuvant atezolizumab improved disease-free survival.
Study: Routine Surveillance Crucial After Radical Cystectomy
Low adherence to post-radical cystectomy surveillance guidelines may increase patients’ mortality risk, study findings suggest.
Prophylactic Ureteral Stenting Linked to Upper Tract Urothelial Carcinoma
In current urological practice, clinicians decide whether to place a ureteral stent or nephrostomy, but evidence-based treatment guidance is needed.
Trodelvy Gets Accelerated Approval for Urothelial Cancer
The accelerated approval was based on data from the multicenter, open-label, phase 2 TROPHY study.
Tecentriq Indication for Prior-Platinum Treated Bladder Cancer Withdrawn
In 2016, the FDA granted accelerated approval to Tecentriq for prior-platinum treated metastatic urothelial carcinoma based on tumor response rate and duration of response.
Bladder Cancer Treatment Regimens
View a cancer treatment regimen chart for bladder cancer, including recommended neoadjuvant and adjuvant chemotherapy options.
- Loading...
Loading...
Loading... 
Loading...